Macrophages--promise and peril
- PMID: 11366018
Macrophages--promise and peril
Abstract
AIDS: Anti-HIV agents can suppress virus levels in blood and lymph nodes by inhibiting HIV from making infected T-cells into virus producers. However, anti-HIV agents are not as effective in suppressing viral replication in cells that are known as macrophages (macs). HIV-infected macs do not die as quickly as infected T-cells, and as macs move through the body, they spread HIV. Macs can hide in places that tend to resist anti-HIV drug penetration, such as the eyes or the brain. AOP-RANTES is one of the few drugs that can block the infection of macs.
Similar articles
-
Macrophages and lymphocytes differentially modulate the ability of RANTES to inhibit HIV-1 infection.J Leukoc Biol. 2003 Nov;74(5):781-90. doi: 10.1189/jlb.0403187. Epub 2003 Jul 15. J Leukoc Biol. 2003. PMID: 12960233
-
Soluble glycosaminoglycans Do not potentiate RANTES antiviral activity on the infection of primary macrophages by human immunodeficiency virus type 1.Virology. 2000 Dec 20;278(2):412-22. doi: 10.1006/viro.2000.0670. Virology. 2000. PMID: 11118364
-
A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication.AIDS. 2006 Apr 24;20(7):975-80. doi: 10.1097/01.aids.0000222068.14878.0d. AIDS. 2006. PMID: 16603848
-
Therapeutic strategies towards HIV-1 infection in macrophages.Antiviral Res. 2006 Sep;71(2-3):293-300. doi: 10.1016/j.antiviral.2006.05.015. Epub 2006 Jun 9. Antiviral Res. 2006. PMID: 16806514 Review.
-
Clinical implications of HIV dynamics and drug resistance in macrophages.J Biol Regul Homeost Agents. 1998;12(1-2 Suppl):23-7. J Biol Regul Homeost Agents. 1998. PMID: 9689575 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous